Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 3481 AL 3495

Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies

Kumar D, Ambasta RK, Kumar P.

Ageing Res Rev. 2020 Aug;61:101078. doi: 10.1016/j.arr.2020.101078. Epub 2020 May 12.

Traffic signaling: new functions of huntingtin and axonal transport in neurological disease

Vitet H, Brandt V, Saudou F.

Curr Opin Neurobiol. 2020 Aug;63:122-130. doi: 10.1016/j.conb.2020.04.001. Epub 2020 May 12.

Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease

González-Guevara E, Cárdenas G, Pérez-Severiano F, Martínez-Lazcano JC.

Mov Disord. 2020 Jul;35(7):1113-1127. doi: 10.1002/mds.28089. Epub 2020 May 15.

Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases

Momtaz S, Memariani Z, El-Senduny FF, Sanadgol N, Golab F, Katebi M, Abdolghaffari AH, Farzaei MH, Abdollahi M.

Front Physiol. 2020 Apr 28;11:361. doi: 10.3389/fphys.2020.00361. eCollection 2020.

Interstitial ions: A key regulator of state-dependent neural activity?

Rasmussen R, O'Donnell J, Ding F, Nedergaard M.

Prog Neurobiol. 2020 Oct;193:101802. doi: 10.1016/j.pneurobio.2020.101802. Epub 2020 May 13.

Biological Aging and the Cellular Pathogenesis of Huntington's Disease

Machiela E, Southwell AL.

J Huntingtons Dis. 2020;9(2):115-128. doi: 10.3233/JHD-200395.

Irritability in Huntington's Disease

Karagas NE, Rocha NP, Stimming EF.

J Huntingtons Dis. 2020;9(2):107-113. doi: 10.3233/JHD-200397.

Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?

Yousefi N, Abdollahii S, Kouhbanani MAJ, Hassanzadeh A.

J Cell Physiol. 2020 Dec;235(12):9166-9184. doi: 10.1002/jcp.29800. Epub 2020 May 21.

Genus Boswellia as a new candidate for neurodegenerative disorders

Rajabian A, Sadeghnia H, Fanoudi S, Hosseini A.

Iran J Basic Med Sci. 2020 Mar;23(3):277-286. doi: 10.22038/IJBMS.2020.35288.8419.

VMAT2 inhibitors for the treatment of hyperkinetic movement disorders

Koch J, Shi WX, Dashtipour K.

Pharmacol Ther. 2020 Aug;212:107580. doi: 10.1016/j.pharmthera.2020.107580. Epub 2020 May 23.

Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior

Srejovic I, Selakovic D, Jovicic N, Jakovljević V, Lukic ML, Rosic G.

Biomolecules. 2020 May 21;10(5):798. doi: 10.3390/biom10050798.

The Application of Ferroptosis in Diseases

Qiu Y, Cao Y, Cao W, Jia Y, Lu N.

Pharmacol Res. 2020 Sep;159:104919. doi: 10.1016/j.phrs.2020.104919. Epub 2020 May 25.

Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration

Uddin MS, Hossain MF, Mamun AA, Shah MA, Hasana S, Bulbul IJ, Sarwar MS, Mansouri RA, Ashraf GM, Rauf A, Abdel-Daim MM, Bin-Jumah MN.

Sci Total Environ. 2020 Jul 10;725:138313. doi: 10.1016/j.scitotenv.2020.138313. Epub 2020 Mar 31.

Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases

Stanga S, Caretto A, Boido M, Vercelli A.

Int J Mol Sci. 2020 May 25;21(10):3719. doi: 10.3390/ijms21103719.

Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice

Reyhani S, Abbaspanah B, Mousavi SH.

Regen Med. 2020 Apr;15(4):1561-1578. doi: 10.2217/rme-2019-0119. Epub 2020 Jun 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias